93 related articles for article (PubMed ID: 18423991)
1. Prediction of very short survival in patients with brain metastases from breast cancer.
Nieder C; Marienhagen K; Thamm R; Astner ST; Molls M; Norum J
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):337-9. PubMed ID: 18423991
[TBL] [Abstract][Full Text] [Related]
2. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
Nieder C; Pawinski A; Molls M
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
4. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
5. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
7. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
8. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the prognosis of breast cancer patients with brain metastases.
Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
[TBL] [Abstract][Full Text] [Related]
11. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.
Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045
[TBL] [Abstract][Full Text] [Related]
12. Outcome of whole-brain irradiation for breast cancer patients.
Johansen R; Westin AA; Bofin AM; Lundgren S
Acta Oncol; 2008; 47(2):261-6. PubMed ID: 17882559
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
14. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
16. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
[TBL] [Abstract][Full Text] [Related]
17. Disease presentation and treatment outcome in very young patients with brain metastases from lung cancer.
Nieder C; Thamm R; Astner ST; Molls M
Onkologie; 2008 Jun; 31(6):305-8. PubMed ID: 18547970
[TBL] [Abstract][Full Text] [Related]
18. Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease.
Meyer A; Steinmann D; Malaimare L; Karstens JH; Bremer M
Anticancer Res; 2008; 28(6B):3965-9. PubMed ID: 19192657
[TBL] [Abstract][Full Text] [Related]
19. HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
Wolstenholme V; Hawkins M; Ashley S; Tait D; Ross G
Breast; 2008 Dec; 17(6):661-5. PubMed ID: 18571923
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
Rades D; Fischer D; Veninga T; Stalpers LJ; Schild SE
Gynecol Oncol; 2009 Sep; 114(3):506-8. PubMed ID: 19540574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
